Valvular heart disease, mainly aortic valve pathology, is frequently associated with aneurysm of the ascending aorta. Indications for surgery depend on the underlying pathology. Increasing age, hypertension, smoking, genetics, atherosclerosis and connective tissue disorders are aetiological factors associated with ascending aortic aneurysms [
1]. When deciding whether or not to replace the aorta and aortic valve we must take many factors into consideration, including patient age, aneurysm size, co-morbidities, type of valve prosthesis and surgeon-specific preference. Surgical mortality for isolated elective replacement of the ascending aorta, including the aortic root, ranges in literature from 1.6–4.8% and largely depends on age and other well-known cardiovascular risk factors at the time of surgery [
2]. However, operative mortality for aortic aneurysm is significantly increased in the elderly patient group [
3]. The risk in aortic surgery is highly dependent on the type of surgery, speed of repair, cross-clamping time and circulatory arrest time [
4]. Furthermore, several studies found a higher incidence of prolonged ventilation times, low cardiac output syndrome, multi-organ failure and post-operative infections in elderly patients compared with a younger age group.
The type of surgery depends on the exact location of the aortic dilatation and the concomitant valvular procedures required. Current guidelines recommend aortic valve repair, using the re-implantation technique or remodelling with aortic annuloplasty, in young patients with aortic root dilation and tricuspid aortic valves [
5]. In comparison to younger patients, little to nothing is known about quality of life after major aortic surgery in elderly patients [
6]. In literature, the average cardiopulmonary bypass times and cross-clamping times are longer for elderly patient (patients > 65 years) with 232 and 170 min for David procedure and 222 and 147 min for Bentall procedure in elderly patients respectively [
7].
We describe an alternative strategy for treatment of ascending aortic aneurysm and aortic valve stenosis to simplify and shorten the surgical procedure.